Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
A recent randomized trial (TOPPS) compared prophylactic platelet transfusions (for counts <10x109/L) with a strategy of no-prophylaxis in adults with hematologic malignancies. 70% of enrolled patients received autologous hematopoietic stem cell transplant (HSCT). In this analysis, statistical...
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Julkaistu: |
Ferrata Storti Foundation
2015
|